Cetera Investment Advisers’s iShares Biotechnology ETF IBB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.77M | Sell |
61,454
-1,467
| -2% | -$186K | 0.01% | 950 |
|
|
2025
Q1 | $8.05M | Sell |
62,921
-2,384
| -4% | -$305K | 0.02% | 867 |
|
|
2024
Q4 | $8.63M | Sell |
65,305
-14,743
| -18% | -$1.95M | 0.02% | 774 |
|
|
2024
Q3 | $11.7M | Sell |
80,048
-11,371
| -12% | -$1.66M | 0.03% | 632 |
|
|
2024
Q2 | $12.5M | Buy |
91,419
+341
| +0.4% | +$46.8K | 0.03% | 582 |
|
|
2024
Q1 | $12.5M | Buy |
91,078
+79,541
| +689% | +$10.9M | 0.03% | 581 |
|
|
2023
Q4 | $1.57M | Sell |
11,537
-879
| -7% | -$119K | 0.01% | 890 |
|
|
2023
Q3 | $1.52M | Sell |
12,416
-2,005
| -14% | -$245K | 0.01% | 860 |
|
|
2023
Q2 | $1.83M | Sell |
14,421
-1,350
| -9% | -$171K | 0.02% | 808 |
|
|
2023
Q1 | $2.04M | Sell |
15,771
-13,403
| -46% | -$1.73M | 0.02% | 726 |
|
|
2022
Q4 | $3.83M | Buy |
29,174
+18,090
| +163% | +$2.38M | 0.04% | 472 |
|
|
2022
Q3 | $1.3M | Sell |
11,084
-13,950
| -56% | -$1.63M | 0.03% | 615 |
|
|
2022
Q2 | $2.95M | Buy |
25,034
+5,691
| +29% | +$669K | 0.05% | 402 |
|
|
2022
Q1 | $2.52M | Sell |
19,343
-2,773
| -13% | -$361K | 0.04% | 475 |
|
|
2021
Q4 | $3.38M | Sell |
22,116
-595
| -3% | -$90.8K | 0.05% | 391 |
|
|
2021
Q3 | $3.67M | Sell |
22,711
-357
| -2% | -$57.7K | 0.06% | 344 |
|
|
2021
Q2 | $3.78M | Buy |
23,068
+284
| +1% | +$46.5K | 0.06% | 334 |
|
|
2021
Q1 | $3.43M | Buy |
22,784
+1,049
| +5% | +$158K | 0.07% | 299 |
|
|
2020
Q4 | $3.29M | Buy |
21,735
+19,186
| +753% | +$2.91M | 0.07% | 306 |
|
|
2020
Q3 | $345K | Sell |
2,549
-2,802
| -52% | -$379K | 0.03% | 468 |
|
|
2020
Q2 | $731K | Buy |
5,351
+3,189
| +148% | +$436K | 0.07% | 292 |
|
|
2020
Q1 | $233K | Sell |
2,162
-290
| -12% | -$31.3K | 0.03% | 457 |
|
|
2019
Q4 | $295K | Sell |
2,452
-1,159
| -32% | -$139K | 0.03% | 455 |
|
|
2019
Q3 | $356K | Sell |
3,611
-685
| -16% | -$67.5K | 0.04% | 368 |
|
|
2019
Q2 | $469K | Sell |
4,296
-167
| -4% | -$18.2K | 0.06% | 308 |
|
|
2019
Q1 | $495K | Buy |
4,463
+203
| +5% | +$22.5K | 0.07% | 279 |
|
|
2018
Q4 | $405K | Sell |
4,260
-14
| -0.3% | -$1.33K | 0.07% | 287 |
|
|
2018
Q3 | $518K | Sell |
4,274
-135
| -3% | -$16.4K | 0.07% | 263 |
|
|
2018
Q2 | $483K | Sell |
4,409
-315
| -7% | -$34.5K | 0.08% | 248 |
|
|
2018
Q1 | $507K | Buy |
4,724
+73
| +2% | +$7.84K | 0.09% | 225 |
|
|
2017
Q4 | $500K | Buy |
4,651
+3,202
| +221% | +$344K | 0.09% | 243 |
|
|
2017
Q3 | $483K | Buy |
1,449
+104
| +8% | +$34.7K | 0.11% | 233 |
|
|
2017
Q2 | $423K | Sell |
1,345
-101
| -7% | -$31.8K | 0.1% | 249 |
|
|
2017
Q1 | $427K | Buy |
1,446
+405
| +39% | +$120K | 0.12% | 222 |
|
|
2016
Q4 | $278K | Buy |
+1,041
| New | +$278K | 0.09% | 250 |
|